Global Artificial Tissue Chips Market Growth 2023-2029

Global Artificial Tissue Chips Market Growth 2023-2029

Artificial Tissue Chip is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and Organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.

LPI (LP Information)' newest research report, the “Artificial Tissue Chips Industry Forecast” looks at past sales and reviews total world Artificial Tissue Chips sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Tissue Chips sales for 2023 through 2029. With Artificial Tissue Chips sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Tissue Chips industry.

This Insight Report provides a comprehensive analysis of the global Artificial Tissue Chips landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Tissue Chips portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Artificial Tissue Chips market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Tissue Chips and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Tissue Chips.

The global Artificial Tissue Chips market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Artificial Tissue Chips is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Artificial Tissue Chips is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Artificial Tissue Chips is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Artificial Tissue Chips players cover Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, Nortis and Micronit Microtechnologies B.V., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Tissue Chips market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Brain-on-a-Chip
Liver-on-a-Chip
Kidney-on-a-Chip
Lung-on-a-Chip
Heart-on-a-Chip
Intestine-on-a-Chip
Vessel-on-a-Chip
Others

Segmentation by application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory

Key Questions Addressed in this Report

What is the 10-year outlook for the global Artificial Tissue Chips market?

What factors are driving Artificial Tissue Chips market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Artificial Tissue Chips market opportunities vary by end market size?

How does Artificial Tissue Chips break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.